Roger Stupp, MD

Roger Stupp, MD, discusses final results of a randomized, multi-center, phase III trial investigating tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma.

Results from the EF-14 trial which compared standard of care for glioblastoma plus or minus the tumor treating fields.